Doxorubicin, primary chemoteurapeutic agent used for breast cancer treatment, is known to have various side effects included multi drug resistance (MDR) phenomenon. Therefore, exploration of co-chemotherapeutic agent is important to be conducted in order to prevent MDR. Secang (Caesalpinia sappan L.) which contains active compounds brazilin and brazilein, is proven to have activity as anticancer. The aim of this study is to determine the potency of Caesalpinia sappan L. ethanolic extract (CEE) as co-chemotherapeutic agent of doxorubicin and its mechanism through apoptosis induction on T47D breast cancer cells. Caesalpinia sappan L. heartwood powder was macerated with ethanol 70%. The cytotoxic effect of CEE alone and its combination with doxorubicin was analyzed using MTT assay. Apoptosis assay was done by flowcytometry-annexin V method. CEE showed cytotoxic activity on T47D cells with IC50 value of 35 µg/ml, while combinatorial test showed that all of combination doses of CEE and doxorubicin gave synergistic effect. Flowcytometry-annexin V assay proved that treatment of CEE induced apoptosis of doxorubicin. Based on these results, we conclude that Caesalpinia sappan L. heartwood ethanolic extract is potential to be developed as co-chemotherapeutic agent of doxorubicin.
INTRODUCTION
Breast cancer is the most frequently diagnosed cancer and the leading cause of death in women (Fang et al., 2011) . Sistem Informasi Rumah Sakit (SIRS)/Hospital Information System mentions that breast cancer ranks first in hospitalized patients in all hospitals in Indonesia (16.85%) (Dinkes, 2010) . Breast cancer shows complex pathological mechanisms, structural changes at the molecular level to determine various aspects that affect the nature of the disease (Dong, 2006) . Malignant nature of cancer, a major challenge in the clinical world, primarily because it has the ability to independently provide sufficient signal growth, inhibits antigrowth signals, capable invaded other tissues and metastasis, has potency to divide in an unlimited amount, capable to form new blood vessels (angiogenesis), and has a mechanism of evasion of apoptosis (programmed cell death) that causes cancer cells to be able to proliferate rapidly (Hanahan and Weinberg, 2011) . Mechanisms in cancer cells avoid apoptosis has become a serious attention in the clinical world, and influenced researcher to aim at developing drugs that can induce apoptosis in cancer cells (Wong, 2011) .
Primary treatment of breast cancer is done with chemotherapy if surgery is not able to cope with cancer that has metastasis. Chemotherapy is a treatment step with a chemical substance that showed cytotoxic activity and work directly on cancer cells (Staerk et al., 2002) .
*Corresponding author e-mail: meiyan_e@ugm.ac.id Doxorubicin is one of many chemotherapeutic agents used in cancer treatment, works by inhibiting the cell cycle at the G2/M phase by inducing DNA damage (Potter et al., 2002) . However, long term used of doxorubicin caused adverse side effects, such as heart problems, nausea, diarrhea, alopecia (Gunawan, 2007) and resistance (Lee, 2010) . Dose reduction is done to reduce the side effects of doxorubicin (Wattanapitayakul et al., 2005) , but it may also reduce its efficacy against cancer cells. Therefore, it is necessary to explore a co-chemotherapy agent which combined with doxorubicin to improve doxorubicin efficacy with lower toxicity to normal tissue.
Secang (Caesalpinia sappan L.) is one of the plants potential to be developed as a cochemotherapeutic agent with doxorubicin. Empirically, secang's heartwood used as the main ingredient in Indonesian traditional beverage such as wedang secang and wedang uwuh. Pharmacologically, it was reported that secang induces cell death in neck cancer and this effect is associated with the increase of p53 and p21 WAF1/CIP1 protein expression at the cellular level (Kim et al., 2005) . Secang also induces apoptosis in several cancer cell types such as human promyelocytic leukemia HL-60 cells (Zhang et al., 2002) , and human leukemia K562 cells (Wang et al., 2001) . The scientific evidence indicates that secang is potential to be developed as a co-chemotherapeutic agent with doxorubicin.
This study was conducted in a series of tests to determine the effect of Secang (Caesalpinia sappan L.) heartwood ethanolic extract alone and its combination with doxorubicin in increasing cytotoxic activity and apoptosis induction of doxorubicin on T47D breast cancer cells. Scientific data obtained from this research can be used as the basic of the application of the Caesalpinia sappan L. heartwood ethanolic extract in the treatment of breast cancer.
MATERIALS AND METHODS

Sample Preparation
Dried Caesalpinia sappan L. shavings heartwood were obtain from Wonosari Yogyakarta, Indonesia. The heartwood then powdered and standardized by Laboratory of Biology, Faculty of Pharmacy Universitas Gadjah Mada. Dried powder was then macerated for 5 days with 70% ethanol. Filtrate was collected then concentrated using rotary evaporator (Heidolph WB2000). For application on cells, Caesalpinia sappan L. ethanolic extract (CEE) was dissolved in dimethyl sulfoxide as co-solvent with concentration 5 mg/ml, and then diluted in DMEM cell culture medium in various concentrations.
Cells Culture
Human breast cancer T47D culture cells were a collection of Cancer Chemoprevention Research Center (CCRC), Universitas Gadjah Mada. The cell line was kindly given by Prof. Kawaichi, Nara Institute of Science and Technology (NAIST), Japan.
Chemicals
Making 100 ml cell culture medium was prepared by mix Dulbecco's Modified Eagle Medium (DMEM) (Gibco) medium stock contain HEPES (Sigma) and sodium bicarbonate (Sigma), 10% v/v Fetal Bovine Serum (FBS) (Gibco), 1% PenicillinStreptomycin (Gibco), and 0,5% Fungizone (Gibco). Tripsin-EDTA 0,25% (Gibco) were used for cell preparation. For cytotoxicity assay, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) reagent were used which was dissolved in PBS with concentration 5 mg/ml. Phosphate Buffer Saline (PBS) pH 7.4 containing KCl (HPLC grade, Sigma), NaCl (HPLC grade, Sigma), Na 2 HPO 4 (HPLC grade, Sigma), and KH 2 PO 4 (HPLC grade, Sigma) dissolved in aquadest as washing reagent and 10% b/v Sodium Dodecyl Sulphate (SDS) (Merck) dissolved in 0.01 N HCl (Merck) as stopper reagent. Annexin-FITC was diluted in binding buffer (10mM HEPES, 100 mM NaCl, 10 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 ) which is contained propidium iodide (50 µg/ml). culture medium was removed and cells were washed using PBS (Sigma). 5 mg/mL of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) on PBS (Sigma) was diluted by DMEM culture medium (1:10) and 100 µl of it was added into each well. After incubated for 3-4 h the reaction was stopped by Sodium Dodecyl Sulfate (SDS) 10% in HCL 0,01 N. After that, the plate was incubated for one night in room condition at dark place. To make sure the formazan was dissolved, the plate was shaked for 10 minutes and the absorbance was then measured using ELISA reader at wave length of 595 nm.
Cytotoxic Assay
Apoptosis Assay
Cells (5x10 5 cells/well) were transferred in to six well tissue culture plate (Iwaki) and incubated for 24 h. Cells were treated with CEE, doxorubicin, and their combination with concentration ½ IC 50 and then incubated for 24 h. After incubation, adherent and detached cells were collected and centrifugated at 2000 rpm for 3 min, then washed twice with cold PBS. Cells were resuspended in 500 µl of Annexin V buffer (Biovision) and then treated with annexin V and propidium iodide for 10 min at 37 o C. The treated cells were then subjected to FACS flowcytometry. Bivariant analysis of FITC-fluoresence (FL-1) and PI-fluoresence (FL-3) gave different cell populations where FITC (-) and PI (-) were designated as viable cells; FITC (+) and PI (-) phenotype as apoptotic cells; FITC (-) and PI (+) as necrotic cells; and FITC (+) and PI (+) as late apoptotic cells.
Data Analysis
Single cytotoxicity assay. (2005), which has the formula as follows.
CI = + +
RESULTS AND DISCUSSION
In order to determine cytotoxic effect of CEE on T47D cells, MTT assay was done with various concentrations of CEE treatments. As shown in Fig. 1, T47D cells viability was decreased after CEE treatment for 24 h in dose dependent manner. The MTT results demonstrated that CEE has potent cytotoxicity against T47D with IC 50 value of 35 µg/ml. Moreover, the present study observed potency of CEE increase doxorubicin's cytotoxicity. Cell morphology after treatment was observed (Fig. 2(A)-2(D) ). Treatment of CEE and doxorubicin alone led to cells' morphological changing, (Fig. 2(B) and 2(C)) compared to control cells (2A). Combination of them caused more changes compared to single treated cells (Fig. 2(D) ). Combination of CEE and doxorubicin with various concentrations reduced percent cells viability as shown in Fig.  2(E) . Combination treatment of CEE and doxorubicin on T47D cells gave synergistic effect in all concentration that tested with CI values less than 0.9, shown in Table I . Synergistic effect caused by combinational treatment of CEE and doxorubicin could be related with apoptosis and/or cell cycle arrest. To evaluate the impact of CEE and doxorubicin induce apoptosis on T47D cells, apoptosis phenomenon were detected using flowcytometric. This method is detected translocation of phosphatidyl serine residues which are normally located in the internal phospholipid layer to external layer in apoptotic cells. The result showed that combination of doxorubicin with CEE induced apoptosis rates of late apoptotic cells, but did not induced early apoptotic cells on T47D cells (Fig. 3) Caesalpinia sappan L. has been used as traditional medicine in various countries including Indonesia. The results of current study demonstrated potentially ability of CEE on inhibiting T47D cells proliferation with IC 50 value of 35 μg/ml in dose dependent manner. While, when combine with doxorubicin, CEE could increase cytotoxic effects of doxorubicin in all tested concentration. This indicates that CEE might perform dominant effect on combination compared to doxorubicin. Combination therapy is a rationale strategy to increase response and tolerability and to decrease resistance. This result indicates that CEE has a potency to be developed as cochemotherapeutic agent for doxorubicin in breast cancer.
Mechanism that mediates cytotoxic activity of CEE on T47D cells can be undergoes by apoptosis and or cell cycle arrest. Kim et al. (2005) reported that Caesalpinia sappan was able to induce expression of p53 and p21 WAF1/CIP1 at cellular level. Caesalpinia sappan has been reported to induce apoptosis in several cancer cell types such as human promyelocytic leukemia HL-60 cells (Zhang et al., 2002) , and human leukemia K562 cells (Wang et al., 2001) . Nurulita and Muflih (2006) reported that secang's methanolic extract has cytotoxic effect on T47D cells with IC 50 value of 150.9 µg/ml, and observations on the morphology of cells after double staining method with ethidium bromide-acridyn orange showed apoptosis phenomenon. The ability to induce apoptosis in cancer cells is an important property of a candidate anticancer drug because cancer cells are capable to evading apoptosis.
The major finding of the present study is an effect of CEE in inducing apoptosis of doxorubicin on T47D cells. Human breast cancer T47D cells are ER/PR-positive cells that express wildtype caspase-3, wildtype caspase-7, and mutant p53 (Bouker et al., 2005; Schafer et al., 2000) . Mutations in p53 gene lead to inhibition of doxorubicin induced apoptosis in T47D cells. Mechanisms that mediate doxorubicin induced apoptosis in T47D cells only through extrinsic pathway by tumor necrosis factor (TNF), so induction of apoptosis is less effective (Keane et al., 1999) . Our study represented that CEE induced apoptosis on T47D cells while treatment alone or combination with doxorubicin compare with control and treatment of doxorubicin alone. However, compare with the combination treatment, administration of CEE alone exhibit no differences percentage of apoptotic cells of T47D cells. This result indicates that CEE might has stronger effect than doxorubicin on T47D cells.
Various studies about C. sappan's active compound have been reported on its anticancer activity. Brazilein, a flavonoid compound of Caesalpinia sappan has been known to cause down-regulation of survivin, and increase activation of caspase-9 and caspase-3 and induce PARP (Poly ADP ribose polymerase) cleavage in HepG2 liver cancer cells (Zhong et al., 2009) . Tao et al. (2011) reported that brazilein is able to improve the sensitivity of K562 and K562/AO2 leukemia cells resistant to doxorubicin chemotherapeutic agents, because brazilein is not a substrate of P-gp protein.
Previous study by Ren et al. (2011) mentioned that brazilin, another compound of Caesalpinia sappan, induced apoptosis of T24 bladder cancer cells, but the mechanisms of this activity not fully understand. These mechanisms might be responsible in apoptosis induction of Caesalpinia sappan in T47D cells. Thus, further study is needed to be conducted.
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